Skip to main content

Find Clinical Trials

Home
Conditions
Hyperphosphatemia

Clinical trial condition

Hyperphosphatemia

Explore clinical trials studying Hyperphosphatemia. Study availability and eligibility vary by location and protocol.

95 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hyperphosphatemia trial results

Completed

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742585

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Chūbu, Japan

Hokkaido, Japan

Kansai, Japan

Kanto, Japan

View Trial Details

Completed

Bioequivalence Study of BAY77-1931 Granule

NCT01053676

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Osaka, Japan

View Trial Details

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

NCT00767637

Conditions: Dialysis, Hyperphosphatemia, Metabolic Diseases, +2 more
Locations: Isesaki, Gunma, Japan

Yonago, Tottori, Japan

View Trial Details

Completed

The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

NCT01854437

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Shiraz University Hemodialysis Center Shiraz, Fars, Iran

View Trial Details

Completed

BAY 77-1931 Long-term Extension From Phase II Study

NCT00769496

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Toyohashi, Aichi-ken, Japan

Yatomi, Aichi-ken, Japan

Chiba, Japan

Kashiwa, Chiba, Japan

View all 14 locations

View Trial Details

Completed

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

NCT01514851

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +14 more
Locations: Toyohashi, Aichi-ken, Japan

Yatomi, Aichi-ken, Japan

Asahi, Chiba, Japan

Chiba, Japan

View all 31 locations

View Trial Details

Completed

Nicotinamide in Hemodialysis Patients With Hyperphosphatemia

NCT01200784

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +15 more
Locations: Alsfeld, Germany

Arnstadt, Germany

Augsburg, Germany

Berlin, Germany

View all 36 locations

View Trial Details

Completed

PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum

NCT01319578

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Denver Nephrologists, PC Denver, Colorado, United States

View Trial Details

Completed

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

NCT00505037

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Chugoku, Japan

Chūbu, Japan

Kansai, Japan

Kanto, Japan

View Trial Details

Completed

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

NCT01057108

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Denver Nephrologists, PC Denver, Colorado, United States

View Trial Details